The shares of Chemours Company (The) (NYSE:CC) and Akers Biosciences Inc (NASDAQ:AKER) were among the active stocks of the last trading sessions. Chemours Company (The) (NYSE:CC) declined to -1.66% closing at the price of $34.37 whereas the shares of Akers Biosciences Inc (NASDAQ:AKER) soared 0% with the increase of 0 points closing at the price of $0.34. Chemours Company (The) has currently decrease -31.83% in its stock over the period of 6-months while its rival Akers Biosciences Inc subtracted -33.69% in the previous 6-months.
Now we have to analyze the facts that if the stocks were worthy off investors’ money? The facts to analyze here are risks, profitability, returns and price trends.
Returns and Profitability
Profitability and returns are the main reason of investment, the investors are looking for profits that they get and return they should expect over the period of time.
The first and foremost return that is considered while making an investment is the ROI or Return on Investment. The ROI is the ratio between the profit against the cost of investment. Currently the ROI of Chemours Company (The) (NYSE:CC) is 17.9% while the ROI of Akers Biosciences Inc (NASDAQ:AKER) is -114%. Another figure that is to be considered while analyzing the profitability of a share is its EBITDA margin, CC’s EBITDA Margin is 5.32 whereas AKER’s is -3.36.
Both the profitability ratios suggest that Chemours Company (The) (NYSE:CC) is more suitable investment in terms of profitability and return.
EPS & Surprise Factor
Chemours Company (The) (NYSE:CC) reported $1.49/share EPS for the previous quarter where analysts were predicting an EPS to be $1.42/share Thus beating the analyst Estimates with a Surprise Factor of 4.9 Percent. While, Akers Biosciences Inc (NASDAQ:AKER) reported EPS of $-0.2/share in the last quarter. The analysts projected EPS of $0.06/share depicting a Surprise of -433.3 Percent.
Taking a look at Earnings per Share, Chemours Company (The) tends to be beating the analyst estimates more than Akers Biosciences Inc. so CC is more profitable than AKER.
Technical Analysis of Chemours Company (The) & Akers Biosciences Inc
Moving average convergence divergence (MACD) shows that Chemours Company (The) (NYSE:CC) is on a PRICE RELATIVITY trend While Akers Biosciences Inc (NASDAQ:AKER) is on PRICE RELATIVITY trend. The trend for the past 10-days shows that the Chemours Company (The) was in BEARISH territory and Akers Biosciences Inc was in BEARISH territory.
CC’s current statistics gauge that the stock candle is BULLISH with MEDIUM volatility. While AKER’s candle is NEUTRAL with HIGH.
EPS Growth Rate: CC’s 1.5% versus AKER’s 0%
Another shareholder value can be analyzed through the EPS growth rate; the next 5 years EPS growth rate is predicted by the analysts after the analyzing the previous trends. The next 5 year EPS growth rate of Chemours Company (The) (NYSE:CC) is predicted at 1.5% while Akers Biosciences Inc (NASDAQ:AKER) stands at 0%. These numbers suggest that CC is more suitable investment in terms of EPS growth rate.
Financial Risk and Liquidity Concerns
The current ratio and the debt ratio are the two ratios that show the investor how quickly the company is able to payout its debt and how quickly it can cover its obligations. The current ratio of CC stands at 2.1 while AKER is at 5.7 whereas the debt ratio of the prior is 3.9 while the debt ratio of the later is 0.
The values of the both ratios suggest that one is more liquid and other investment is more risk free.
While making an investment, another main factor to consider before investing is the analyst recommendation on the scale of 1 to 5 where 1 is strong buy, 2 is buy, 3 is hold, 4 is Sell and 5 is strong sell. Analyst recommend 2.1 for CC and 2 for AKER which means CC has Hold rating whereas AKER has Buy rating.
Another recommendation of analyst that is to be considered worthy is the price target. The mare price or price trend does not suggest the suitability of a stock. The price target set by analyst is also to be considered while investing as it suggests to what extent the stock will rise or fall in the near future. The price target set for CC is $54 which is 36.35% of its current price while AKER has price target of 4 which is 91.5% of its current price.
Valuation is the process of determining the company’s worth for an investor, the valuation ratios give an insight to that worthiness.
CC currently has price to earning P/E ratio of 6.16 whereas AKER has 0 while the forward P/E ratio for the prior stands at 5.53 and for the later it depicts the value of 0.
The price to Book P/B for CC is 6, Price to Sale is at 0.92 and for AKER these ratios stand at 2.83 and 13.34.